5-Fluorouracil: identification of novel downstream mediators of tumour response

John Boyer, Pamela J Maxwell, Daniel B Longley, Patrick G Johnston

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)

Abstract

5-Fluorouracil (5-FU) is routinely used in the treatment of gastrointestinal, breast and head and neck cancers. A major limitation to the use of this drug is acquired or inherent resistance.
Original languageEnglish
Pages (from-to)417-23
Number of pages7
JournalAnticancer Research
Volume24
Issue number2A
Publication statusPublished - 2004

Fingerprint Dive into the research topics of '5-Fluorouracil: identification of novel downstream mediators of tumour response'. Together they form a unique fingerprint.

Cite this